126% Average Gains While Stocks Crash

From Weiss Ratings | Ad

Investors have lost $15 trillion so far, and it's about to get much worse. But Dr. Martin Weiss offers the solution with “Crash Profits Trades.”

These could have produced average gains of 126% with NO losing trades, even with stocks tumbling!

Click here to discover Crash Profit Trades.

>>>

ADVM Insider Trading (Adverum Biotechnologies)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.40%

Insider Buying (Last 12 Months): $178,806.33

Insider Selling (Last 12 Months): $119,342.22

Adverum Biotechnologies Insider Trading History Chart

Adverum Biotechnologies Share Price & Price History

^$1.54

▲ +0.05 (3.36%)

As of 08/10/2022 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Adverum Biotechnologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/23/2022	Setareh Seyedkazemi	Insider	Buy	20,000	$0.84	$16,800.00	20,600
5/17/2022	Rupert D'souza	CFO	Buy	10,000	$0.83	$8,300.00	20,850
5/16/2022	Dawn Svoronos	Director	Buy	30,000	$0.85	$25,500.00	50,000
5/13/2022	Rupert D'souza	CFO	Buy	10,000	$0.86	$8,600.00	10,850
4/20/2022	Laurent Fischer	CEO	Buy	25,000	$1.11	$27,750.00	762,462
4/19/2022	Kishor Peter Soparkar	Insider	Buy	21,925	$1.14	$24,994.50	280,556
12/8/2021	Laurent Fischer	CEO	Buy	10,677	$1.79	$19,111.83
12/8/2021	Kishor Peter Soparkar	Insider	Buy	25,000	$1.91	$47,750.00
11/15/2021	James Paul Scopa	Director	Sell	50,000	$2.18	$109,000.00
9/30/2021	Julie Clark	Insider	Sell	4,766	$2.17	$10,342.22
3/24/2021	Laurent Fischer	CEO	Buy	10,000	$9.88	$98,800.00	26,292
2/9/2021	Leone D Patterson	CFO	Sell	12,533	$14.10	$176,715.30	98,017
1/15/2021	Laurent Fischer	CEO	Buy	8,600	$11.53	$99,158.00	16,292
1/15/2021	Patrick Machado	Director	Buy	10,000	$11.52	$115,200.00	78,182
8/17/2020	Kishor Peter Soparkar	insider	Buy	7,692	$13.00	$99,996.00	7,692
7/20/2020	Mehdi Gasmi	Director	Sell	5,000	$17.60	$88,000.00	279,442
6/22/2020	Mehdi Gasmi	Director	Sell	23,605	$25.06	$591,541.30	298,047
6/18/2020	Mehdi Gasmi	Director	Sell	11,395	$25.01	$284,988.95	274,710
6/16/2020	Leone D Patterson	President	Sell	13,171	$24.68	$325,060.28	110,488
6/15/2020	Mehdi Gasmi	Director	Sell	10,000	$21.86	$218,600.00	284,442
5/20/2020	Mehdi Gasmi	Director	Sell	1,401	$20.01	$28,034.01	275,843
5/18/2020	Mehdi Gasmi	Director	Sell	5,000	$18.17	$90,850.00
5/6/2020	Leone D. Patterson	CEO	Sell	20,000	$20.02	$400,400.00
5/6/2020	Mehdi Gasmi	Director	Sell	25,000	$20.03	$500,750.00
3/20/2020	Leone D Patterson	CEO	Sell	39,526	$10.17	$401,979.42	162,955
3/17/2020	Leone D Patterson	CEO	Sell	474	$10.02	$4,749.48	138,531
2/14/2020	James Paul Scopa	Director	Buy	10,000	$15.79	$157,900.00
2/12/2020	Mehdi Gasmi	Director	Sell	10,000	$15.07	$150,700.00	321,418

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Adverum Biotechnologies (NASDAQ:ADVM)

77.82% of Adverum Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adverum Biotechnologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	117,512	$0.14M	0.0%	-61.2%	0.119%
8/1/2022	Monaco Asset Management SAM	447,004	$0.54M	0.2%	N/A	0.453%
7/27/2022	Assenagon Asset Management S.A.	941,751	$1.13M	0.0%	-5.1%	0.953%
7/15/2022	Marquette Asset Management LLC	132,769	$0.16M	0.0%	+101.9%	0.134%
6/7/2022	Bank of America Corp DE	30,889	$40K	0.0%	-91.2%	0.031%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	387,623	$0.51M	0.0%	-9.2%	0.392%
5/17/2022	Mirabella Financial Services LLP	24,200	$32K	0.0%	N/A	0.025%
5/17/2022	RTW Investments LP	223,725	$0.29M	0.0%	-97.0%	0.227%
5/16/2022	Goldman Sachs Group Inc.	264,273	$0.35M	0.0%	-45.5%	0.268%
5/16/2022	State Street Corp	1,757,495	$2.30M	0.0%	-4.5%	1.780%
5/16/2022	Invesco Ltd.	286,314	$0.38M	0.0%	+996.9%	0.290%
5/13/2022	Renaissance Technologies LLC	396,441	$0.52M	0.0%	-38.1%	0.401%
5/13/2022	Northern Trust Corp	758,580	$0.99M	0.0%	-4.0%	0.768%
5/13/2022	Charles Schwab Investment Management Inc.	195,885	$0.26M	0.0%	-9.4%	0.198%
5/13/2022	Vanguard Group Inc.	3,536,364	$4.63M	0.0%	-16.7%	3.581%
5/13/2022	Dimensional Fund Advisors LP	593,619	$0.78M	0.0%	-13.6%	0.601%
5/12/2022	BlackRock Inc.	7,315,539	$9.58M	0.0%	-0.4%	7.408%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	302,717	$0.40M	0.0%	-10.6%	0.307%
5/11/2022	JPMorgan Chase & Co.	1,687,273	$2.21M	0.0%	-18.1%	1.709%
5/11/2022	GSA Capital Partners LLP	395,585	$0.52M	0.1%	-24.3%	0.401%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	387,623	$0.51M	0.0%	-9.2%	0.393%
5/5/2022	Russell Investments Group Ltd.	76,637	$100K	0.0%	-50.0%	0.078%
4/26/2022	Marquette Asset Management LLC	65,754	$86K	0.0%	+21.8%	0.067%
4/25/2022	Assenagon Asset Management S.A.	992,729	$1.30M	0.0%	+125.8%	1.005%
2/15/2022	683 Capital Management LLC	100,000	$0.18M	0.0%	-50.0%	0.102%
2/14/2022	Quinn Opportunity Partners LLC	503,004	$0.89M	0.1%	+102.8%	0.512%
2/14/2022	GSA Capital Partners LLP	522,284	$0.92M	0.1%	N/A	0.532%
2/11/2022	K2 Principal Fund L.P.	420,944	$0.74M	0.0%	-74.5%	0.429%
2/10/2022	Rafferty Asset Management LLC	49,107	$86K	0.0%	+47.9%	0.050%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	338,740	$0.60M	0.0%	-8.1%	0.345%
2/9/2022	BNP Paribas Arbitrage SA	175,109	$0.31M	0.0%	+872.0%	0.178%
2/9/2022	Dimensional Fund Advisors LP	687,130	$1.21M	0.0%	-8.1%	0.700%
2/9/2022	First Republic Investment Management Inc.	16,167	$28K	0.0%	-35.8%	0.016%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	427,008	$0.75M	0.0%	+58.8%	0.435%
2/8/2022	Northern Trust Corp	790,397	$1.39M	0.0%	-9.9%	0.805%
2/7/2022	SG Americas Securities LLC	24,489	$43K	0.0%	-64.5%	0.025%
2/1/2022	Assenagon Asset Management S.A.	439,574	$0.77M	0.0%	-70.0%	0.448%
1/21/2022	Russell Investments Group Ltd.	153,337	$0.27M	0.0%	-31.8%	0.156%
1/19/2022	Marquette Asset Management LLC	54,000	$95K	0.0%	+18.4%	0.055%
12/14/2021	UBS Asset Management Americas Inc.	173,979	$0.38M	0.0%	+26.2%	0.177%
11/16/2021	Squarepoint Ops LLC	33,825	$73K	0.0%	+26.2%	0.034%
11/16/2021	Two Sigma Advisers LP	1,766,900	$3.83M	0.0%	+81.2%	1.800%
11/16/2021	Two Sigma Investments LP	1,870,697	$4.06M	0.0%	+23.0%	1.906%
11/16/2021	UBS Group AG	3,143,669	$6.82M	0.0%	+0.7%	3.203%
11/15/2021	Man Group plc	65,591	$0.14M	0.0%	-49.2%	0.067%
11/15/2021	RTW Investments LP	7,483,757	$16.24M	0.2%	+1.7%	7.625%
11/15/2021	Caxton Associates LP	124,850	$0.27M	0.0%	+342.4%	0.127%
11/15/2021	683 Capital Management LLC	200,000	$0.43M	0.0%	N/A	0.204%
11/15/2021	Dimensional Fund Advisors LP	747,329	$1.62M	0.0%	-41.6%	0.761%
11/12/2021	Renaissance Technologies LLC	1,106,777	$2.40M	0.0%	+36.8%	1.128%
11/12/2021	Jump Financial LLC	26,600	$58K	0.0%	+117.4%	0.027%
11/12/2021	K2 Principal Fund L.P.	1,653,874	$3.59M	0.3%	+84.1%	1.685%
11/12/2021	Geode Capital Management LLC	1,533,929	$3.33M	0.0%	-4.2%	1.563%
11/12/2021	WS Management Lllp	188,616	$0.41M	0.0%	-38.6%	0.192%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	368,405	$0.80M	0.0%	N/A	0.375%
11/10/2021	Goldman Sachs Group Inc.	884,703	$1.92M	0.0%	+7.9%	0.902%
11/10/2021	Citigroup Inc.	69,416	$0.15M	0.0%	-90.7%	0.071%
11/10/2021	Rafferty Asset Management LLC	33,199	$72K	0.0%	-92.6%	0.034%
11/10/2021	Alliancebernstein L.P.	112,300	$0.24M	0.0%	-9.1%	0.114%
11/9/2021	Barclays PLC	49,306	$0.11M	0.0%	-16.4%	0.050%
11/9/2021	BlackRock Inc.	7,435,074	$16.13M	0.0%	-6.9%	7.577%
11/9/2021	Principal Financial Group Inc.	19,364	$42K	0.0%	-40.5%	0.020%
11/4/2021	Deutsche Bank AG	49,988	$0.11M	0.0%	-90.6%	0.051%
11/1/2021	SG Americas Securities LLC	68,934	$0.15M	0.0%	N/A	0.070%
10/21/2021	Virginia Retirement Systems ET AL	42,800	$93K	0.0%	+23.0%	0.044%
10/19/2021	Assenagon Asset Management S.A.	1,466,807	$3.18M	0.0%	-9.8%	1.495%
10/12/2021	Marquette Asset Management LLC	45,603	$99K	0.0%	N/A	0.046%
9/17/2021	Virtu Financial LLC	73,955	$0.26M	0.0%	N/A	0.075%
9/3/2021	Parametric Portfolio Associates LLC	143,051	$0.50M	0.0%	+233.6%	0.146%
8/17/2021	Walleye Capital LLC	234,185	$0.82M	0.0%	N/A	0.239%
8/17/2021	Walleye Trading LLC	54,711	$0.19M	0.0%	N/A	0.056%
8/17/2021	Man Group plc	128,991	$0.45M	0.0%	+161.7%	0.131%
8/17/2021	Price T Rowe Associates Inc. MD	54,095	$0.19M	0.0%	-90.7%	0.055%
8/17/2021	Prudential Financial Inc.	51,484	$0.18M	0.0%	N/A	0.052%
8/16/2021	Squarepoint Ops LLC	26,807	$94K	0.0%	N/A	0.027%
8/16/2021	UBS Asset Management Americas Inc.	137,867	$0.48M	0.0%	-76.3%	0.140%
8/16/2021	Cubist Systematic Strategies LLC	82,959	$0.29M	0.0%	+226.4%	0.085%
8/16/2021	California State Teachers Retirement System	119,815	$0.42M	0.0%	-10.7%	0.122%
8/16/2021	Occudo Quantitative Strategies LP	85,104	$0.30M	0.0%	+350.3%	0.087%
8/16/2021	Caxton Associates LP	28,222	$99K	0.0%	N/A	0.029%
8/16/2021	Morgan Stanley	958,190	$3.35M	0.0%	+32.7%	0.976%
8/16/2021	Charles Schwab Investment Management Inc.	616,913	$2.16M	0.0%	+0.9%	0.629%
8/16/2021	State Street Corp	9,574,242	$33.51M	0.0%	+81.5%	9.757%
8/16/2021	Nuveen Asset Management LLC	475,069	$4.83M	0.0%	+10.9%	0.484%
8/16/2021	Avoro Capital Advisors LLC	6,950,000	$24.33M	0.4%	-13.1%	7.083%
8/16/2021	Goldman Sachs Group Inc.	819,955	$2.87M	0.0%	-41.4%	0.836%
8/16/2021	Allianz Asset Management GmbH	60,468	$0.21M	0.0%	-73.9%	0.062%
8/13/2021	RTW Investments LP	7,357,917	$25.75M	0.4%	+0.1%	7.498%
8/13/2021	Renaissance Technologies LLC	809,280	$2.83M	0.0%	+539.4%	0.825%
8/13/2021	Northern Trust Corp	921,899	$3.23M	0.0%	-6.1%	0.940%
8/13/2021	Algert Global LLC	82,145	$0.29M	0.1%	+13.9%	0.084%
8/13/2021	Virginia Retirement Systems ET AL	34,800	$0.12M	0.0%	N/A	0.035%
8/13/2021	Jump Financial LLC	12,238	$43K	0.0%	-71.4%	0.012%
8/13/2021	Geode Capital Management LLC	1,600,688	$5.60M	0.0%	+6.5%	1.631%
8/13/2021	Vanguard Group Inc.	4,345,771	$15.21M	0.0%	-5.2%	4.429%
8/12/2021	WS Management Lllp	307,442	$1.08M	0.1%	-56.5%	0.313%
8/12/2021	Dimensional Fund Advisors LP	1,279,810	$4.48M	0.0%	-8.5%	1.304%
8/12/2021	JPMorgan Chase & Co.	2,340,336	$8.19M	0.0%	+18.5%	2.385%
8/12/2021	Ergoteles LLC	37,200	$0.13M	0.0%	N/A	0.038%
8/11/2021	Bank of New York Mellon Corp	306,030	$1.07M	0.0%	-5.1%	0.312%

Data available starting January 2016

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Today's Range

Now: $1.54

$1.48

$1.54

50 Day Range

MA: $1.32

$0.92

$1.75

52 Week Range

Now: $1.54

$0.80

$2.57

Volume

109,518 shs

Average Volume

1,209,719 shs

Market Capitalization

$152.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Adverum Biotechnologies?: Adverum Biotechnologies' top insider shareholders include:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Leone D Patterson (CFO)
Patrick Machado (Director)
Dawn Svoronos (Director)
Rupert D'souza (CFO)
Setareh Seyedkazemi (Insider)
James Paul Scopa (Director)
Julie Clark (Insider)
Learn More about top insider investors at Adverum Biotechnologies.
Who are the major institutional investors of Adverum Biotechnologies?: Adverum Biotechnologies' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.95%
Monaco Asset Management SAM — 0.45%
Marquette Asset Management LLC — 0.13%
Connor Clark & Lunn Investment Management Ltd. — 0.12%
Learn More about top institutional investors of Adverum Biotechnologies stock.
Which major investors are selling Adverum Biotechnologies stock?: Within the previous quarter, ADVM stock was sold by these institutional investors:
Connor Clark & Lunn Investment Management Ltd.
Assenagon Asset Management S.A.
During the last year, company insiders that have sold Adverum Biotechnologies company stock include:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Learn More investors selling Adverum Biotechnologies stock.
Which major investors are buying Adverum Biotechnologies stock?: In the last quarter, ADVM stock was bought by institutional investors including:
Monaco Asset Management SAM
Marquette Asset Management LLC
In the previous year, these company insiders have bought Adverum Biotechnologies stock:
Laurent Fischer (CEO)
Peter Soparkar (Insider)
Leone D Patterson (CFO)
Patrick Machado (Director)
Dawn Svoronos (Director)
Rupert D'souza (CFO)
Learn More investors buying Adverum Biotechnologies stock.